468 articles across injectables, lasers, body contouring, skin therapeutics, and provider safety.
Thread lifts are marketed as a quick facelift alternative, but complications and scar tissue matter. Learn what can go wrong and how it affects future surgery.
Letybo is the newest FDA-approved neuromodulator in the U.S. Here is how it compares to Botox, Dysport, and Xeomin on onset, duration, unit conversion, cost, and patient…
RF microneedling and Fraxel both improve texture and scars through different mechanisms. Compare results, downtime, cost, and skin type safety.
RHA and Juvéderm are hyaluronic acid filler families with different strengths. Compare movement, structure, longevity, cost, and patient fit.
Baby Botox and regular Botox use the same drug at different doses. Here is how the dosing philosophy differs, what each approach can and cannot do, and who each is for.
Botox Cosmetic typically lasts 3–4 months, but duration varies by treatment area, dose, metabolism, and which neuromodulator you use. Here is what the evidence and the…
Jeuveau and Dysport are both FDA-approved botulinum toxin type A products, but they differ in unit dosing, onset speed, tissue spread, and ideal use cases. Here is how…
Compares PDL, KTP, IPL, and Nd:YAG for rosacea by evidence, best use, downtime, cost, and skin-type safety so you can have an informed conversation with your provider.
Filler usually does not prevent a facelift, but years of injections can affect surgical planning. Learn which fillers matter and what to ask before surgery.
Filler can shift from where it was injected. Learn what migration means, which areas and products are prone, and when hyaluronidase dissolving helps.